Share the Video:

Therapeutic Frontiers of DMT and Ayahuasca: Safety, Depression, and Mental Health Q&A

Fernanda Palhano-Fontes, Graham Campbell, Michelle Baker Jones, Rafael Guimarães dos Santos

Dimethyltryptamine (DMT), a potent and rapidly acting psychedelic, is the subject of increasing scientific interest for its therapeutic potential. This session will explore the latest research on DMT, including the development of novel psychotherapeutic frameworks specifically designed for its use in treating major depression. Presenters will also discuss the findings from recent clinical trials examining the safety and tolerability of inhaled DMT, as well as insights gained from ayahuasca research, another powerful DMT-containing brew, and its impact on mental health. Join us for a comprehensive overview of the current state of DMT research and its implications for future therapeutic applications.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Related Videos